John Schollum

2.8k total citations
43 papers, 2.1k citations indexed

About

John Schollum is a scholar working on Nephrology, Psychiatry and Mental health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John Schollum has authored 43 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Nephrology, 8 papers in Psychiatry and Mental health and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John Schollum's work include Dialysis and Renal Disease Management (18 papers), Chronic Kidney Disease and Diabetes (7 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (5 papers). John Schollum is often cited by papers focused on Dialysis and Renal Disease Management (18 papers), Chronic Kidney Disease and Diabetes (7 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (5 papers). John Schollum collaborates with scholars based in New Zealand, Australia and United Kingdom. John Schollum's co-authors include Peter Croft, A J Silman, Robert Walker, Alan J. Silman, Alan S. Rigby, Gary J. Macfarlane, P Croft, Stephen B. Duffull, Frederiek E. Vos and Carolyn V. Coulter and has published in prestigious journals such as PLoS ONE, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

John Schollum

41 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Schollum New Zealand 19 778 769 707 267 182 43 2.1k
Jie Dong China 28 1.4k 1.8× 302 0.4× 53 0.1× 325 1.2× 274 1.5× 125 2.5k
Ariel Berger United States 25 82 0.1× 501 0.7× 629 0.9× 280 1.0× 413 2.3× 82 2.1k
Geoffrey E. Moore United States 20 447 0.6× 179 0.2× 49 0.1× 302 1.1× 312 1.7× 43 1.5k
Luigi Tazza Italy 25 1.1k 1.4× 261 0.3× 42 0.1× 355 1.3× 403 2.2× 78 1.8k
Stig Mølsted Denmark 17 366 0.5× 106 0.1× 112 0.2× 184 0.7× 194 1.1× 84 1.0k
João L. Viana Portugal 27 781 1.0× 109 0.1× 51 0.1× 410 1.5× 713 3.9× 75 2.1k
Christian Temml Austria 27 573 0.7× 635 0.8× 130 0.2× 521 2.0× 106 0.6× 37 2.7k
Jonathan M. Sorof United States 29 656 0.8× 184 0.2× 122 0.2× 650 2.4× 378 2.1× 62 4.8k
Mariacristina Vecchio France 17 922 1.2× 297 0.4× 26 0.0× 197 0.7× 241 1.3× 24 1.7k
Andreas Egli Switzerland 14 91 0.1× 183 0.2× 121 0.2× 201 0.8× 406 2.2× 29 1.8k

Countries citing papers authored by John Schollum

Since Specialization
Citations

This map shows the geographic impact of John Schollum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Schollum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Schollum more than expected).

Fields of papers citing papers by John Schollum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Schollum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Schollum. The network helps show where John Schollum may publish in the future.

Co-authorship network of co-authors of John Schollum

This figure shows the co-authorship network connecting the top 25 collaborators of John Schollum. A scholar is included among the top collaborators of John Schollum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Schollum. John Schollum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wilson, Luke C., et al.. (2024). The impact of peritoneal dialysis on oxypurinol and urate elimination in people with gout. Nephrology. 29(8). 547–550. 1 indexed citations
3.
Walker, Robert, et al.. (2022). Health-Related Quality of Life and Disability Among Older New Zealanders With Kidney Failure: A Prospective Study. Canadian Journal of Kidney Health and Disease. 9. 1025049912–1025049912. 1 indexed citations
4.
Wilson, Luke C., et al.. (2021). Metformin doses to ensure efficacy and safety in patients with reduced kidney function. PLoS ONE. 16(2). e0246247–e0246247. 11 indexed citations
5.
McNoe, Bronwen, John Schollum, Sarah Derrett, et al.. (2019). Recruitment and participant baseline characteristics in the dialysis outcomes in those aged 65 years or older study. BMC Nephrology. 20(1). 137–137. 4 indexed citations
6.
Wright, Daniel F. B., Jason A. Roberts, Stephen B. Duffull, et al.. (2019). The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF). European Journal of Clinical Pharmacology. 76(2). 239–247. 3 indexed citations
7.
Lovell, Sarah, Robert Walker, John Schollum, et al.. (2017). To dialyse or delay: a qualitative study of older New Zealanders’ perceptions and experiences of decision-making, with stage 5 chronic kidney disease. BMJ Open. 7(3). e014781–e014781. 29 indexed citations
8.
Derrett, Sarah, Ari Samaranayaka, John Schollum, et al.. (2017). Predictors of Health Deterioration Among Older Adults After 12 Months of Dialysis Therapy: A Longitudinal Cohort Study From New Zealand. American Journal of Kidney Diseases. 70(6). 798–806. 14 indexed citations
9.
Duffull, Stephen B., et al.. (2016). A Population Pharmacokinetic Model for 51Cr EDTA to Estimate Renal Function. Clinical Pharmacokinetics. 56(6). 671–678. 2 indexed citations
10.
Dunlop, Joanna, Alain C. Vandal, Janak de Zoysa, et al.. (2014). Rationale and design of the myocardial microinjury and cardiac remodeling extension study in the sodium lowering in dialysate trial (Mac-SoLID study). BMC Nephrology. 15(1). 120–120. 4 indexed citations
11.
Duffull, Stephen B., et al.. (2014). GFR may not accurately predict aspects of proximal tubule drug handling. European Journal of Clinical Pharmacology. 70(10). 1221–1226. 17 indexed citations
12.
Walker, Robert, John P. Leader, Jennifer J. Bedford, et al.. (2012). Chronic interstitial fibrosis in the rat kidney induced by long-term (6-mo) exposure to lithium. American Journal of Physiology-Renal Physiology. 304(3). F300–F307. 31 indexed citations
13.
Johnson, David W., Mary Clarke, Neil Boudville, et al.. (2012). The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial. Nephrology Dialysis Transplantation. 27(12). 4445–4453. 67 indexed citations
14.
Johnson, David W., Fiona G. Brown, Margaret Clarke, et al.. (2012). Effects of Biocompatible versus Standard Fluid on Peritoneal Dialysis Outcomes. Journal of the American Society of Nephrology. 23(6). 1097–1107. 125 indexed citations
15.
Vos, Frederiek E., John Schollum, Carolyn V. Coulter, et al.. (2011). Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Nephrology. 17(2). 182–188. 86 indexed citations
16.
Vos, Frederiek E., et al.. (2011). Modeling red blood cell survival data. Journal of Pharmacokinetics and Pharmacodynamics. 38(6). 787–801. 13 indexed citations
17.
Vos, Frederiek E., et al.. (2011). Red Blood Cell Survival in Long-term Dialysis Patients. American Journal of Kidney Diseases. 58(4). 591–598. 114 indexed citations
18.
Derrett, Sarah, et al.. (2010). Older peoples' satisfaction with home‐based dialysis. Nephrology. 15(4). 464–470. 22 indexed citations
19.
Huggan, Paul, et al.. (2008). Sustained low‐efficiency dialysis with filtration (SLEDD‐f) in the management of acute sodium valproate intoxication. Hemodialysis International. 12(2). 211–214. 22 indexed citations
20.
Croft, Peter, John Schollum, & Alan J. Silman. (1994). Population study of tender point counts and pain as evidence of fibromyalgia. BMJ. 309(6956). 696–699. 218 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jie Dong Breakdown of academic impact, for papers by Ariel Berger Breakdown of academic impact, for papers by Geoffrey E. Moore Breakdown of academic impact, for papers by Luigi Tazza Breakdown of academic impact, for papers by Stig Mølsted Breakdown of academic impact, for papers by João L. Viana Breakdown of academic impact, for papers by Christian Temml Breakdown of academic impact, for papers by Jonathan M. Sorof Breakdown of academic impact, for papers by Mariacristina Vecchio Breakdown of academic impact, for papers by Andreas Egli
Rankless by CCL
2026